| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |